These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 33412914)

  • 21. Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration.
    Maulvi FA; Shetty KH; Desai DT; Shah DO; Willcox MDP
    Int J Pharm; 2021 Oct; 608():121105. PubMed ID: 34537269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular delivery systems for topical application of anti-infective agents.
    Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Rupenthal ID; Al-Kassas R
    Drug Dev Ind Pharm; 2016 Jan; 42(1):1-11. PubMed ID: 26325119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prodrugs and nanomicelles to overcome ocular barriers for drug penetration.
    Gote V; Ansong M; Pal D
    Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):885-906. PubMed ID: 32729364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
    Lakhani P; Patil A; Majumdar S
    Ther Deliv; 2018 Feb; 9(2):137-153. PubMed ID: 29325511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended ocular drug delivery systems for the anterior and posterior segments: biomaterial options and applications.
    Kang-Mieler JJ; Dosmar E; Liu W; Mieler WF
    Expert Opin Drug Deliv; 2017 May; 14(5):611-620. PubMed ID: 27551742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview.
    Almeida H; Amaral MH; Lobão P; Sousa Lobo JM
    Expert Opin Drug Deliv; 2013 Sep; 10(9):1223-37. PubMed ID: 23688342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
    Srinivasarao DA; Lohiya G; Katti DS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of ocular drug delivery systems using molecularly imprinted soft contact lenses.
    Tashakori-Sabzevar F; Mohajeri SA
    Drug Dev Ind Pharm; 2015 May; 41(5):703-13. PubMed ID: 25113431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Designing lipid nanoparticles for topical ocular drug delivery.
    Alvarez-Trabado J; Diebold Y; Sanchez A
    Int J Pharm; 2017 Oct; 532(1):204-217. PubMed ID: 28893582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanotechnology in ocular drug delivery.
    Sahoo SK; Dilnawaz F; Krishnakumar S
    Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of lipid nanoparticles to ocular drug delivery.
    Battaglia L; Serpe L; Foglietta F; Muntoni E; Gallarate M; Del Pozo Rodriguez A; Solinis MA
    Expert Opin Drug Deliv; 2016 Dec; 13(12):1743-1757. PubMed ID: 27291069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colloidal carriers for ophthalmic drug delivery.
    Mainardes RM; Urban MC; Cinto PO; Khalil NM; Chaud MV; Evangelista RC; Gremiao MP
    Curr Drug Targets; 2005 May; 6(3):363-71. PubMed ID: 15857294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging potential of niosomes in ocular delivery.
    Verma A; Tiwari A; Saraf S; Panda PK; Jain A; Jain SK
    Expert Opin Drug Deliv; 2021 Jan; 18(1):55-71. PubMed ID: 32903034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of the ocular therapeutic effect of prednisolone acetate by liposomal entrapment.
    Elbialy NS; Abdol-Azim BM; Shafaa MW; El Shazly LH; El Shazly AH; Khalil WA
    J Biomed Nanotechnol; 2013 Dec; 9(12):2105-16. PubMed ID: 24266264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Light activated liposomes: Functionality and prospects in ocular drug delivery.
    Lajunen T; Nurmi R; Kontturi L; Viitala L; Yliperttula M; Murtomäki L; Urtti A
    J Control Release; 2016 Dec; 244(Pt B):157-166. PubMed ID: 27565215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Ocular Drug Delivery Systems: An Update on Microemulsions.
    Üstündağ Okur N; Çağlar EŞ; Siafaka PI
    J Ocul Pharmacol Ther; 2020; 36(6):342-354. PubMed ID: 32255728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraocular distribution of topically applied hydrophilic and lipophilic substances in rat eyes.
    Abdul Nasir NA; Agarwal P; Agarwal R; Iezhitsa I; Alyautdin R; Nukolova NN; Chekhonin VP; Mohd Ismail N
    Drug Deliv; 2016 Oct; 23(8):2765-2771. PubMed ID: 26289215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microrobots: a new era in ocular drug delivery.
    Fusco S; Ullrich F; Pokki J; Chatzipirpiridis G; Özkale B; Sivaraman KM; Ergeneman O; Pané S; Nelson BJ
    Expert Opin Drug Deliv; 2014 Nov; 11(11):1815-26. PubMed ID: 25001411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of ocular drug delivery.
    Sultana Y; Jain R; Aqil M; Ali A
    Curr Drug Deliv; 2006 Apr; 3(2):207-17. PubMed ID: 16611007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.